Who benefits from medical interventions?
暂无分享,去创建一个
[1] G L Drusano,et al. A controlled trial of early versus late treatment with zidovudine in symptomatic human immunodeficiency virus infection. Results of the Veterans Affairs Cooperative Study. , 1992, The New England journal of medicine.
[2] Salim Yusuf,et al. Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. , 1991, The New England journal of medicine.
[3] S W Lagakos,et al. Zidovudine in Asymptomatic Human Immunodeficiency Virus Infection , 1990 .
[4] Walker,et al. Collaborative overview of randomised trials of antiplatelet therapy Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients , 1994 .
[5] R. Collins,et al. Blood pressure, stroke, and coronary heart disease Part 2, short-term reductions in blood pressure: overview of randomised drug trials in their epidemiological context , 1990, The Lancet.
[6] G Rose,et al. Sick individuals and sick populations. , 1985, International journal of epidemiology.
[7] Thomas E. Moritz,et al. Antiplatelet or anticoagulant therapy after coronary artery bypass surgery. A meta-analysis of clinical trials. , 1989, Annals of internal medicine.
[8] C. McCollum,et al. Antiplatelet drugs in femoropopliteal vein bypasses: a multicenter trial. , 1991, Journal of vascular surgery.
[9] M. Alderman,et al. Blood Pressure Management: Individualized Treatment Based on Absolute Risk and the Potential for Benefit , 1993, Annals of Internal Medicine.
[10] M A Fischl,et al. The efficacy of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex. A double-blind, placebo-controlled trial. , 1987, The New England journal of medicine.
[11] P Barham,et al. Management of raised blood pressure in New Zealand: a discussion document. , 1993, BMJ.
[12] S. Khuri,et al. The effect of antiplatelet therapy on saphenous vein coronary artery bypass graft patency. , 1983, Circulation.
[13] J. Aboulker,et al. Preliminary analysis of the Concorde trial , 1993, The Lancet.
[14] Daniel Steinberg,et al. Report of the National Cholesterol Education Program Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. The Expert Panel. , 1988, Archives of internal medicine.
[15] S. Rahimtoola,et al. Failure of antiplatelet and anticoagulant therapy to improve patency of grafts after coronary-artery bypass: a controlled, randomized study. , 1979, The New England journal of medicine.
[16] F. Song,et al. Cholesterol lowering and mortality: the importance of considering initial level of risk. , 1993, BMJ.
[17] Therapy Study Investigators. Effect of ramipril on mortality and morbidity of survivors of acute myocardial infarction with clinical evidence of heart failure , 1993, The Lancet.
[18] D L Sackett,et al. An assessment of clinically useful measures of the consequences of treatment. , 1988, The New England journal of medicine.
[19] M. Oliver. Sounding board. Risks of correcting the risks of coronary disease and stroke with drugs. , 1982, The New England journal of medicine.
[20] P. Hartigan,et al. Cost effectiveness analysis of early zidovudine treatment of HIV infected patients. , 1993, BMJ.
[21] T. Merigan,et al. Placebo-controlled trial to evaluate zidovudine in treatment of human immunodeficiency virus infection in asymptomatic patients with hemophilia. NHF-ACTG 036 Study Group. , 1991, Blood.
[22] E. J. Brown,et al. Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators. , 1992, The New England journal of medicine.
[23] K. Swedberg,et al. Effects of enalapril on mortality in severe congestive heart failure: results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS). , 1988, The American journal of cardiology.
[24] S. Yusuf,et al. Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions. , 1992, The New England journal of medicine.
[25] C D Naylor,et al. Measured Enthusiasm: Does the Method of Reporting Trial Results Alter Perceptions of Therapeutic Effectiveness? , 1992, Annals of Internal Medicine.
[26] J. Copeland,et al. Starting Aspirin Therapy After Operation: Effects on Early Graft Patency , 1991, Circulation.
[27] L. Hillis,et al. The use of aspirin in ischemic heart disease. , 1992, The New England journal of medicine.
[28] Douglas D. Richman,et al. The safety and efficacy of zidovudine (AZT) in the treatment of subjects with mildly symptomatic human immunodeficiency virus type 1 (HIV) infection a double-blind, placebo-controlled trial , 1990 .
[29] G. Murray,et al. Effect of ramipril on mortality and morbidity of survivors of acute myocardial infarction with clinical evidence of heart failure. The Acute Infarction Ramipril Efficacy (AIRE) Study Investigators , 1993 .
[30] J. Mckenney,et al. Summary of the second report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II) , 1993, JAMA.